Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $15.7 Million - $19.5 Million
20,300 Added 71.23%
48,800 $43.2 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $8.26 Million - $10.4 Million
11,400 Added 66.67%
28,500 $25.8 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $1.24 Million - $1.66 Million
-2,100 Reduced 10.94%
17,100 $13.3 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $10.1 Million - $11.9 Million
19,200 New
19,200 $11.2 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $332,400 - $409,064
1,500 Added 1500.0%
1,600 $370,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $18,055 - $23,354
100 New
100 $23,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.